Denali Therapeutics Inc. - COMMON STOCK (DNLI)

CUSIP: 24823R105

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 7 signals
Share change
+2,336,348
Put/Call ratio
39%
SEC-reported price per share
$24.18
Indexed holders
142
Value change
+$63,425,607
Number of buys
83
Open additional details 1 more signal available
Number of sells
46
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
159,626,106

Security key

24823R105

Report period

Q2 2020

Indexed institutions

142

Top holders

10

Ownership snapshot

Top reported holders of DNLI - Denali Therapeutics Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Crestline Management, L.P.
Disclosed value leader
Crestline Management, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2020
13F Highest disclosed value: $272,591,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Crestline Management, L.P. has the largest disclosed position value at $272.59M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Crestline Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Crestline Management, L.P. $272.59M
BAILLIE GIFFORD & CO $159.86M
Flagship Pioneering, LLC $139.73M
VANGUARD GROUP INC $120.96M
BlackRock Finance, Inc. $92.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Crestline Management, L.P.
13F
Company
13F
—
denominator unverified
$272,591,000
15,567,736 shares
— 31 Mar 2020
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$159,861,000
9,129,752 shares
— 31 Mar 2020
Flagship Pioneering, LLC
13F
Company
13F
—
denominator unverified
$139,734,000
7,980,263 shares
— 31 Mar 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$120,965,000
6,908,331 shares
— 31 Mar 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$92,213,000
5,266,356 shares
— 31 Mar 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$91,501,000
5,225,670 shares
— 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
142
Shares
82,768,394
Indexed holders
142
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 indexed holders
127
Q2 2020 indexed holders
142
Indexed holder difference
15
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .